Utang jangka cendhak marang ekuitas: chromadex.com (CDXC)

The market price for ChromaDex Corporation (CDXC) on the GURU.Markets platform, which stands at 0.02 as confirmed by the chart, reflects the activity of this longevity supplement manufacturer. The business competes with numerous small players for consumer trust. Demand for health and wellness products is moderately dependent on economic cycles and inflation. Through the expansion of distribution and profit growth, ChromaDex Corporation (CDXC) has achieved financial autonomy without the threat of funding shortages.

This indicator assesses liquidity risk by comparing liabilities with maturities of up to one year against equity, as reflected in the trend of the short-term debt-to-equity ratio. A decrease in this ratio confirms the financial stability of ChromaDex Corporation (CDXC), whose B2B licensing model for Niagen minimizes retail operating costs, allowing for the effective management of short-term debt loads without compromising business scaling.